[Primary esophageal motor disorders in childhood, genuine achalasia excluded]

E Devouge1, L Michaud, M D Lamblin

  • 1Unité de gastroentérologie, hépatologie et nutrition, clinique de pédiatrie, hôpital Jeanne-de-Flandre, 2, avenue Oscar-Lambret, 59037 Lille, France.

Insights

Partial achalasia in children presents with varied symptoms like dysphagia and reflux. While some respond to nifedipine, others may need surgery, highlighting the need for careful follow-up.

Area of Science:

  • Pediatric Gastroenterology
  • Esophageal Motility Disorders

Background:

  • Esophageal manometry is crucial for diagnosing primary esophageal disorders in children, including partial achalasia.
  • Partial achalasia presents with diverse clinical symptoms, necessitating a thorough understanding of its manifestations.

Purpose of the Study:

  • To describe the clinical features of partial achalasia in pediatric patients.
  • To identify specific characteristics of partial achalasia.
  • To evaluate the clinical and manometric evolution of partial achalasia in response to treatment.

Main Methods:

  • Retrospective study of 18 pediatric patients diagnosed with partial achalasia between 1990 and 1998.
  • Symptomatology included dysphagia, gastroesophageal reflux, and swallowing disorders.
  • Ancillary investigations comprised pH-metry, esophageal endoscopy, and barium transit studies.

Main Results:

  • Twelve children received nifedipine treatment; six showed good clinical response, while others had no effect or transient improvement.
  • Four children required Heller procedure after nifedipine treatment, and six patients developed achalasia or recurrent symptoms necessitating surgery.
  • No initial clinical or manometric features could predict which patients would have a favorable outcome versus those requiring surgery.

Conclusions:

  • Partial achalasia in children is associated with varied clinical presentations.
  • The potential for disease progression to achalasia or persistent symptoms underscores the importance of vigilant clinical and manometric monitoring.
Abstract

Related Concept Videos

Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.